Page last updated: 2024-08-26

1-methyltryptophan and Carcinoma, Ductal, Pancreatic

1-methyltryptophan has been researched along with Carcinoma, Ductal, Pancreatic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, CH; Jiang, J; Jiang, W; Liao, YP; Liu, X; Lu, J; Meng, H; Nel, AE; Salazar, F; Sun, B; Wang, X; Wu, AM	1

Other Studies

1 other study(ies) available for 1-methyltryptophan and Carcinoma, Ductal, Pancreatic

Article	Year
Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression. Nature communications, 2017, 11-27, Volume: 8, Issue:1 Topics: Adaptive Immunity; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Drug Carriers; Feasibility Studies; Female; Forkhead Transcription Factors; Humans; Immune Tolerance; Immunity, Innate; Immunotherapy; Indoleamine-Pyrrole 2,3,-Dioxygenase; Male; Mice; Nanoparticles; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Phospholipids; Porosity; Prodrugs; Silicon Dioxide; T-Lymphocytes, Cytotoxic; Tissue Distribution; Tryptophan; Xenograft Model Antitumor Assays	2017

Article

Year

Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression.

Nature communications, 2017, 11-27, Volume: 8, Issue:1

Topics: Adaptive Immunity; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Drug Carriers; Feasibility Studies; Female; Forkhead Transcription Factors; Humans; Immune Tolerance; Immunity, Innate; Immunotherapy; Indoleamine-Pyrrole 2,3,-Dioxygenase; Male; Mice; Nanoparticles; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Phospholipids; Porosity; Prodrugs; Silicon Dioxide; T-Lymphocytes, Cytotoxic; Tissue Distribution; Tryptophan; Xenograft Model Antitumor Assays

2017